Morphogene Biotech Private Limited, a active private limited company, was established on 09 April 2013 in Indore, Madhya Pradesh, India. Engaging in agro retail & distribution within the trade sector, it holds CIN: U24233MP2013PTC030485. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.33 Cr.
It upholds a compliant status. Its leadership includes Sanjay Periwal (Director), Karan Kumar Kakkad (Director). Past directors included Rajshree Mohta, Ajay Kumar Singhania, Krishna Kumar Singhania. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Babadeep Complex 7/1, Maharani Road, Indore, Madhya Pradesh, 452007.
U24233MP2013PTC030485
030485
09 April 2013
₹2.00 Cr
₹1.33 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Morphogene Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Periwal | Director | 26 Aug 2013 | Current |
| Karan Kumar Kakkad | Director | 26 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 May 2025 | Past |
| Pramod Abcsdd | Director | 01 Dec 2015 | Past |
| Pramod Abcsdd | Director | 01 Dec 2015 | Past |
| Pramod Abcsdd | Director | 26 Apr 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Morphogene Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 80.12% decrease. The company also saw a substantial fall in profitability, with a 89.81% decrease in profit. The company's net worth dipped by a decrease of 4.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Morphogene Biotech had a promoter holding of 2.26% and a public holding of 97.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Morphogene Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Morphogene Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morphogene Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Morphogene Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Morphogene Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.
Progress on Karan Kumar Kakkad was appointed as a Director was appointed as a Director on 26 Apr 2018 & has been associated with this company since 7 years 7 months . was documented.
The activity Sanjay Periwal was appointed as a Director was appointed as a Director on 26 Aug 2013 & has been associated with this company since 12 years 3 months . was completed.
The activity Morphogene Biotech Private Limited was registered on 09 Apr 2013 with Roc Gwalior & aged 12 years 7 months as per MCA records. was completed.
The CIN of Morphogene Biotech Private Limited is U24233MP2013PTC030485.
Morphogene Biotech Private Limited is headquartered at 3Rd Floor, Babadeep Complex 7/1, Maharani Road, Indore, Madhya Pradesh, 452007.
Morphogene Biotech Private Limited was incorporated on 09 April 2013.
The current directors of Morphogene Biotech Private Limited are
The primary industry of Morphogene Biotech Private Limited is Trade.
Morphogene Biotech Private Limited is unlisted.
The authorized capital of Morphogene Biotech Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.33 Cr.
The compliance status of Morphogene Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX